Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR
Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Standard platinum-based therapy for ovarian cancer is inefficient against ovarian clear cell carcinoma (OCCC). OCCC is a distinct subtype of epithelial ovarian cancer. OCCC constitutes 25% of ovarian cancers in East Asia (Japan, Korea, China, Singapore) and 6-10% in Europe and North America. The cancer is characterized by frequent inactivation of A...
Alternative Titles
Full title
Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_085f030e8b1144f18f14b1e5bcb913e7
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_085f030e8b1144f18f14b1e5bcb913e7
Other Identifiers
ISSN
1757-2215
E-ISSN
1757-2215
DOI
10.1186/s13048-023-01160-y
